Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2025-12-24 @ 5:59 PM
NCT ID:
NCT02775968
Eligibility Criteria:
Inclusion Criteria:
* Children 1-18 years old of both sexes, with a diagnosis of community acquired pneumonia and eligible for treatment with cephalosporins and macrolide antibiotics, as per current treatment protocols.
* Community acquired pneumonia diagnostic criteria: meet any one of the 1-4 following items plus the fifth item:
* 1\. With cough, expectoration, or pre-existing respiratory disease getting worse, and with purulent sputum with or without chest pain;
* 2\. Fever;
* 3\. With pulmonary consolidation and crackles;
* 4\. White blood cells\>10×10\^9/L or \<4×10\^9/L;
* 5\. X-ray on chest shows flake, patchy infiltrate shadows or interstitial changes, with or without pleural effusion.
* Informed consent signed by the parents, and consent or assent of the patients (according to age and consenting capacity).
Exclusion Criteria:
* It is unable to provide complete medical records or the current condition can not accept the diagnosis process.
* It does not agree to participate in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
18 Years
Study:
NCT02775968
Study Brief:
Protocol Section:
NCT02775968